Triple-negative breast cancer (TNBC) presents as a subtype express estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her-2) insufficiently. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.